Director, Division of Infectious Disease Diagnostics - Department of Pathology and Laboratory Medicine Northwell Health Laboratories
BIOGRAPHY
MAR 29, 2021 8:00 AM PDT
Design and performance characteristics of Alinity m Resp-4-Plex assay
Speakers
-
Shihai Huang, Ph.D
Sr. Director of Assay Development, Molecular Diagnostics at AbbottBIOGRAPHY
Event Date & Time
Date: March 29, 2021
Time: 8:00am PDT, 11:00am EDT
Abstract
Influenza (Flu) and COVID-19 are both contagious respiratory illnesses, but they are caused by different viruses. COVID-19 is caused by infection with a new coronavirus (called SARS-CoV-2), and Flu is caused by infection with influenza viruses.1 Due to symptom similarities between Flu and COVID-19, testing is needed to help confirm a diagnosis.1 Being able to simultaneously identify patient’s infection status allows physicians the ability to provide optimal treatment decisions and control further disease transmission. Alinity m Resp-4-Plex assay provides simultaneous qualitative detection and differentiation of Flu A, Flu B, Respiratory Syncytial Virus (RSV) and SARS-CoV-2 on the fully automated Alinity m system. This webinar will discuss the design, development and clinical performance of the Alinity m Resp-4-Plex assay.
Learning Objectives:
- Discuss Respiratory Disease State and Current Trends Overview
- Discuss the Alinity m Resp-4-Plex Assay Design
- Discuss Alinity m Resp-4-Plex Assay Clinical Performance
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...